Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Cancer Hospital of Chinese Academy of Medical Sciences · Beijing

Dr. Shi Yuankai石远凯

Chief Physician · Professor
Deputy department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

SY

Professional overview

Shi Yuankai is a Chief Physician and Professor in the Department of Medical Oncology at Cancer Hospital of Chinese Academy of Medical Sciences. Clinical work and research focus on medical treatment of solid tumors, autologous hematopoietic stem cell transplantation, and clinical trials of novel antitumor drugs with related translational research.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor, Master's Supervisor
DepartmentDepartment of Medical Oncology
HospitalCancer Hospital of Chinese Academy of Medical Sciences
CityBeijing
Hospital roleDeputy Director of National Cancer Center

Department leadership

Deputy department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Lung cancerMedical treatment of lung cancer
LymphomaMedical treatment of malignant lymphoma
Gastric cancerMedical treatment of gastrointestinal cancers
Breast cancerMedical treatment of breast cancer
Prostate cancerMedical treatment of malignant tumors of the urinary and male reproductive systems

Background

  • 1978Studied Japanese Medical Program, School of Medicine, China Medical University (6-year program)
  • 1985Completed Master's degree in Oncology, China Medical University
  • 1989Studied at Osaka University Graduate School of Medicine, Japan
  • 1992Completed PhD in Oncology, Peking Union Medical College; began working at Cancer Hospital, Chinese Academy of Medical Sciences
  • 1996Visiting scholar at University of Alabama at Birmingham
  • 2000Visiting scholar at The University of Texas MD Anderson Cancer Center
  • 2005Served as Director of the Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences
  • 2010Appointed Deputy Director of National Anticancer Drug Clinical Research Center
  • 2012Appointed Director of Beijing Key Laboratory for Clinical Research of Antitumor Molecular Targeted Drugs
  • 2015Appointed Deputy Director of National Cancer Center

Experience & recognition

  • Led 38 research projects including National Science and Technology Support Program and 'Major New Drug Creation' Science and Technology Major Project
  • Published 316 papers, including 58 SCI-indexed articles in journals such as The Lancet and The Lancet Oncology
  • First or corresponding author of 218 papers
  • Edited or translated 18 books; contributed to 15 others
  • Chaired development of 9 national clinical guidelines and expert consensus documents including the 'Chinese Guidelines for Diagnosis and Treatment of Primary Lung Cancer (2015 Edition)' and 'Chinese Guidelines for Diagnosis and Treatment of Malignant Lymphoma (2015 Edition)'
  • Recipient of State Council Special Allowance (1997)
  • Second contributor to National Science and Technology Progress Award, First Class (2015)
  • First contributor to six provincial or ministerial-level Science and Technology Progress Awards, First Class

Professional roles

  • Vice President, Asian Organization for Clinical Oncology (AOCO)
  • President, Chinese Medical Doctor Association (CMDA) Society of Oncologists
  • Standing Committee Member, China Anti-Cancer Association (CACA)
  • Director, CACA Professional Committee on Clinical Chemotherapy of Malignant Tumors
  • Incoming Chair, CACA Lymphoma Professional Committee
  • Vice Chair, CACA Cancer Rehabilitation Society
  • Vice Chair, CACA Targeted Therapy Professional Committee
  • Director, Chinese Pharmaceutical Association (CPA) Professional Committee on Anticancer Drugs

Frequently asked questions

What does Dr. Shi Yuankai specialize in?

Medical treatment of solid tumors including lung cancer, malignant lymphoma, gastrointestinal cancers, breast cancer, and malignant tumors of the urinary and male reproductive systems; autologous hematopoietic stem cell transplantation; clinical trials of novel antitumor drugs and related translational research

Which hospital and department is Dr. Shi Yuankai in?

Department of Medical Oncology at Cancer Hospital of Chinese Academy of Medical Sciences

Sources

Dr. Shi Yuankai has not reviewed this page.